CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Jiaoda Onlly Co., Ltd. Company Snapshot
Shanghai Jiaoda Onlly Co., Ltd. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Jiaoda Onlly Co., Ltd. with three other companies in this sector in China: Shanghai Hile Bio-Technology Co Ltd (2017 sales of 303.65 million Chinese Renmimbi [US$44.11 million] of which 100% was Animal Vaccine), Zhejiang Wolwo Bio Pharmaceutical Co Ltd (385.58 million Chinese Renmimbi [US$56.01 million] of which 99% was Pharmaceutical Manufacturing), and Jiangsu Sihuan Bioengineering Co., Ltd. (345.94 million Chinese Renmimbi [US$50.25 million] of which 94% was Medicine).

Sales Analysis. During the year ended December of 2017, sales at Shanghai Jiaoda Onlly Co., Ltd. were 282.07 million Chinese Renmimbi (US$40.97 million). This is an increase of 5.2% versus 2016, when the company's sales were 268.22 million Chinese Renmimbi. Sales of Real Estate saw an increase that was more than double the company's growth rate: sales were up 65.1% in 2017, from 8.93 million Chinese Renmimbi to 14.74 million Chinese Renmimbi. Shanghai Jiaoda Onlly Co., Ltd. also saw significant increases in sales in Industry (up 12.4% to 141.88 million Chinese Renmimbi) . Not all segments of Shanghai Jiaoda Onlly Co., Ltd. experienced an increase in sales in 2017: sales of Other Operations fell 30.3% to 2.58 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Jiaoda Onlly Co., Ltd.
  Stock Performance Chart for Shanghai Jiaoda Onlly Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 5.39
(Figures in Chinese Renmimbi)
1 Week 2.3%   13 Weeks -2.2%  
4 Weeks -9.4%   52 Weeks -7.4%  
 
Shanghai Jiaoda Onlly Co., Ltd. Key Data:
  Ticker: 600530 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 282,074,421
(Year Ending Jan 2018).
Employees: 529
  Currency: Chinese Renmimbi Market Cap: 4,204,200,000
  Fiscal Yr Ends: December Shares Outstanding: 780,000,000
  Share Type: A Gu Closely Held Shares: 392,167,860
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.